{"url_path":"/sec/kapa/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/1962011/0001493152-26-027200-index.html","accession_number":"0001493152-26-027200","cik":"0001962011","ticker":"KAPA","issuer_name":"Kairos Pharma, LTD.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1962011/0001493152-26-027200-index.html","primary_entity_key":"0001962011","primary_entity_name":"Kairos Pharma, LTD."},"word_count":82,"has_tables":true,"body_markdown":"**Item 9.01.**\n**Financial Statement and Exhibits.**\n\n \n\n(d)\nExhibits.\n\n \n\n**Exhibit No.**\n \n**Description**\n\n99.1\n \n[Press Release dated June 4, 2026](ex99-1.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the\nInline XBRL document).\n\n \n\n2\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned hereunto duly authorized.\n\n \n\n \nIPOWER, INC.\n\nDated: June 4, 2026\n \n \n\n \nBy:\n*/s/ John S. Yu*\n\n \nName: \nJohn S. Yu\n\n \nTitle:\nChief Executive Officer\n\n \n\n3"}